PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition

Epithelial-to-mesenchymal transition (EMT) is a central developmental process implicated in cancer metastasis. Here we show that the tyrosine kinase PYK2 enhances cell migration and invasion and potentiates EMT in human breast carcinoma. EMT inducer, such as EGF, induces rapid phosphorylation of PYK2 and its translocation to early endosomes where it co-localizes with EGFR and sustains its downstream signals. Furthermore, PYK2 enhances EGF-induced STAT3-phosphorylation, while phospho-STAT3 directly binds to PYK2 promoter and regulates PYK2 transcription. STAT3 and PYK2 also enhance c-Met expression, while c-Met augments their phosphorylation, suggesting a positive feedback loop between PYK2-STAT3-c-Met. We propose that PYK2 sustains endosomal-derived receptor signalling and participates in a positive feedback that links cell surface receptor(s) to transcription factor(s) activation, thereby prolonging signalling duration and potentiating EMT. Given the role of EMT in breast cancer metastasis, we also found a significant correlation between PYK2 expression, tumour grade and lymph node metastasis, thus, demonstrating the clinicopathological implication of our findings.

[1]  R. Lefkowitz,et al.  Src-dependent Tyrosine Phosphorylation Regulates Dynamin Self-assembly and Ligand-induced Endocytosis of the Epidermal Growth Factor Receptor* , 2002, The Journal of Biological Chemistry.

[2]  J. Darnell,et al.  Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Boris N. Kholodenko,et al.  Crosstalk and Signaling Switches in Mitogen-Activated Protein Kinase Cascades , 2012, Front. Physiol..

[4]  Michael D Schaller,et al.  Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.

[5]  Xuedong Liu,et al.  Transforming Growth Factor (cid:2) Depletion Is the Primary Determinant of Smad Signaling Kinetics (cid:1) , 2022 .

[6]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[7]  W. Birchmeier,et al.  Targeting MET in cancer: rationale and progress , 2012, Nature Reviews Cancer.

[8]  M. Nieto,et al.  The Snail genes as inducers of cell movement and survival: implications in development and cancer , 2005, Development.

[9]  S. Lev,et al.  The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis , 2014, Journal of Cell Science.

[10]  Benjamin L Turner,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S3 Table S1 References Robust, Tunable Biological Oscillations from Interlinked Positive and Negative Feedback Loops , 2022 .

[11]  C. Nelson,et al.  New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. , 2012, International review of cell and molecular biology.

[12]  G. Moreno-Bueno,et al.  Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.

[13]  A. Dulak,et al.  HGF-independent Potentiation of EGFR Action by c-Met , 2011, Oncogene.

[14]  V. Litvak,et al.  Targeting of PYK2 to Focal Adhesions as a Cellular Mechanism for Convergence between Integrins and G Protein-coupled Receptor Signaling Cascades* , 2000, The Journal of Biological Chemistry.

[15]  Christopher A Lipinski,et al.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. , 2005, Neoplasia.

[16]  A. Vecchione,et al.  Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling , 2014, Oncotarget.

[17]  S. Fan,et al.  Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition , 2011, PloS one.

[18]  Stuart K. Kim,et al.  Signaling specificity: the RTK/RAS/MAP kinase pathway in metazoans. , 1999, Trends in genetics : TIG.

[19]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[20]  L. Trusolino,et al.  The Met oncogene and basal-like breast cancer: another culprit to watch out for? , 2010, Breast Cancer Research.

[21]  S. Roura,et al.  Regulation of E-cadherin/catenin association by tyrosine phosphorylation. , 2016, The Journal of Biological Chemistry.

[22]  Sheng-Chieh Hsu,et al.  Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. , 2005, Cancer cell.

[23]  D. Stolz,et al.  Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells* , 2000, The Journal of Biological Chemistry.

[24]  X. Chen,et al.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.

[25]  E. Wang,et al.  Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. , 2008, Lung cancer.

[26]  Michael J. Allingham,et al.  ICAM-1-Mediated, Src- and Pyk2-Dependent Vascular Endothelial Cadherin Tyrosine Phosphorylation Is Required for Leukocyte Transendothelial Migration1 , 2007, The Journal of Immunology.

[27]  J. Aten,et al.  Measurement of co‐localization of objects in dual‐colour confocal images , 1993, Journal of microscopy.

[28]  C. Lipinski,et al.  Targeting Pyk2 for therapeutic intervention , 2010, Expert opinion on therapeutic targets.

[29]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[30]  Jenny G. Parvani,et al.  TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer , 2013, Oncogene.

[31]  H. Schwarz,et al.  Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion , 1992, Cell.

[32]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[33]  T. Sjöblom,et al.  Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. , 2008, Oncogene.

[34]  Chao Zhang,et al.  Chemical genetic analysis of the time course of signal transduction by JNK. , 2006, Molecular cell.

[35]  Desma M. Grice,et al.  Non-Stimulated, Agonist-Stimulated and Store-Operated Ca2+ Influx in MDA-MB-468 Breast Cancer Cells and the Effect of EGF-Induced EMT on Calcium Entry , 2012, PloS one.

[36]  S. Stacker,et al.  Lymphatic vessels in cancer metastasis: bridging the gaps. , 2006, Carcinogenesis.

[37]  R. Aft,et al.  Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial–Mesenchymal Transition Predicts for Human Breast Cancer Recurrence , 2011, Molecular Cancer Research.

[38]  S. Fan,et al.  Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. , 2008, Carcinogenesis.

[39]  Jinwon Seo,et al.  MET is a potential target for use in combination therapy with EGFR inhibition in triple‐negative/basal‐like breast cancer , 2014, International journal of cancer.

[40]  Mary J. C. Hendrix,et al.  ErbB/EGF Signaling and EMT in Mammary Development and Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[41]  Edda Klipp,et al.  Quantitative analysis of transient and sustained transforming growth factor-β signaling dynamics , 2011, Molecular systems biology.

[42]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[43]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[44]  S. Marley,et al.  Subcellular distribution of p210BCR-ABL in CML cell lines and primary CD34+ CML cells , 2008, Leukemia.

[45]  C. Turner,et al.  Hic-5 promotes invadopodia formation and invasion during TGF-β–induced epithelial–mesenchymal transition , 2012, The Journal of cell biology.

[46]  Ming-Sound Tsao,et al.  An overview of the c-MET signaling pathway , 2011, Therapeutic advances in medical oncology.

[47]  R. Cardiff,et al.  Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer , 2009, Proceedings of the National Academy of Sciences.

[48]  Y. Toiyama,et al.  Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. , 2013, Carcinogenesis.

[49]  Y. Yarden,et al.  Src promotes destruction of c-Cbl: Implications for oncogenic synergy between Src and growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Hideo Baba,et al.  Epithelial–mesenchymal transition in cancer development and its clinical significance , 2010, Cancer science.

[51]  Ronald C. Petersen,et al.  Conversion , 2006, Neurology.

[52]  Bianca Sperl,et al.  Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.

[53]  H. Shibuya,et al.  TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. , 2010, Molecular cell.

[54]  Sima Lev,et al.  Structural Requirements for VAP-B Oligomerization and Their Implication in Amyotrophic Lateral Sclerosis-associated VAP-B(P56S) Neurotoxicity* , 2010, The Journal of Biological Chemistry.

[55]  M. Dimopoulos,et al.  High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer , 2013, British Journal of Cancer.

[56]  Sima Lev,et al.  The phosphatidylinositol‐transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling , 2013, EMBO reports.

[57]  Sheng-Chieh Hsu,et al.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. , 2007, Cancer research.

[58]  Sendurai A Mani,et al.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression , 2011, Breast Cancer Research.

[59]  Sandra Kleiner,et al.  Activation of the c‐Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3 , 2005, Journal of cellular biochemistry.

[60]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[61]  T. Bismar,et al.  Tumorigenesis and Neoplastic Progression Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness , 2010 .

[62]  C. D’Souza-Schorey,et al.  Lysosomal Targeting of E-Cadherin: a Unique Mechanism for the Down-Regulation of Cell-Cell Adhesion during Epithelial to Mesenchymal Transitions , 2005, Molecular and Cellular Biology.

[63]  A. Sorkin,et al.  Endocytosis of receptor tyrosine kinases. , 2013, Cold Spring Harbor perspectives in biology.

[64]  P. V. van Diest,et al.  Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. , 2008, Biochemical and biophysical research communications.

[65]  E. Peles,et al.  Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.

[66]  C. D’Souza-Schorey.  Disassembling adherens junctions: breaking up is hard to do. , 2005, Trends in cell biology.

[67]  R. Jove,et al.  Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis , 2002, Oncogene.

[68]  B. Barton,et al.  STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5′ and 3′ ends , 2008, Molecular Cancer Therapeutics.

[69]  A. Sorkin,et al.  Endocytosis and signalling: intertwining molecular networks , 2009, Nature Reviews Molecular Cell Biology.

[70]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[71]  S. Véronneau,et al.  Signal-Regulated Kinase Activation Mobilization and Extracellular Platelet-Activating Factor-Mediated Calcium Caveolae Facilitate but Are Not Essential for , 2009 .